Hague Court of Appeal (CoA) sets Dutch approach to the doctrine equivalence reversing District Court, handing Eli Lilly another win in its pan-European battle over infringement of its pemetrexed patents and bringing it in line with approaches taken elsewhere in Europe like in Germany and in the UK.
Centogene and Anylam launch clinical programme
Latest NewsDiagnostics developer Centogene NV and Alnylam Pharmaceuticals launched a clinical programme aimed at improving ATTRv diagnosis.
Avantium NV bags money for demo plant
Latest NewsGreen chemistry company Avantium NV has secured a €7.5m funding from the National Programme Groningen to support the construction of a 5 kilotonnes FDCA plant.
22nd German Biotech Guide now also digital!
ProductsThe digital version of the 22nd Guide to German Biotech Companies is now available via the free BIOCOM App! Available for smartphone and tablet users via Apple App Store and Android Store.
How stress brings cancer to life again
Latest NewsStress hormones such as cortisol or norephidrine can reawaken dormant tumour cells, a research team led by AstraZeneca has found out.
Apaxen S.A. appoints CEO
AppointmentsBart Wuurman joined the young Belgian biotechnology company Apaxen S.A. in November as new CEO.
UK approves Biontech/Pfizer Covid-19 vaccine (copy 1)
Latest NewsBiontech and Pfizer have received emergency approval for their COVID-19 vaccine in the UK. Mass immunization could start next week, the first in Western countries.
UK approves Biontech/Pfizer Covid-19 vaccine
Latest NewsBiontech and Pfizer have received emergency approval for their COVID-19 vaccine in the UK. Mass immunization could start next week, the first in Western countries.
Harmonisation of patent law without the UPC?
OpinionHague Court of Appeal (CoA) sets Dutch approach to the doctrine equivalence reversing District Court, handing Eli Lilly another win in its pan-European battle over infringement of its pemetrexed patents and bringing it in line with approaches taken elsewhere in Europe like in Germany and in the UK.
Swiss Noema Pharma raises CHF54m in Series A financing
Latest NewsNoema Pharma AG kicks off with CHF54m and licenced drug candidates from Roche AG.
Germany first EU country to launch COVID-19 therapy offensive?
Latest NewsAfter months of lobbying by the BIOM biotech cluster, Bavaria is launching a €50m initiative to push the best and fastest COVID-19 therapies.